Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

ClinicalTrials.gov ID: NCT00003217

Public ClinicalTrials.gov record NCT00003217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 3:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study of Dose Intensification of Methotrexate and Cyclophosphamide in Patients With Advanced-Stage (III/IV) Small Non-Cleaved Non-Hodgkins Lymphoma and B-Cell All- A Limited Institution Phase III Pilot Study

Study identification

NCT ID
NCT00003217
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Children's Oncology Group
Network
Enrollment
20 participants

Conditions and interventions

Interventions

  • cyclophosphamide Drug
  • cytarabine Drug
  • dexamethasone Drug
  • doxorubicin hydrochloride Drug
  • filgrastim Biological
  • methotrexate Drug
  • vincristine sulfate Drug

Drug · Biological

Eligibility (public fields only)

Age range
Up to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 1998
Primary completion
Sep 30, 2004
Completion
Aug 31, 2006
Last update posted
Jul 24, 2014

1998 – 2006

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
Lucile Packard Children's Hospital at Stanford Palo Alto California 94304
Children's Memorial Hospital, Chicago Chicago Illinois 60614
Hackensack University Medical Center Hackensack New Jersey 07601
Roswell Park Cancer Institute Buffalo New York 14263-0001
University of Rochester Cancer Center Rochester New York 14642
State University of New York - Upstate Medical University Syracuse New York 13210
Oklahoma Memorial Hospital Oklahoma City Oklahoma 73126-0307
Medical University of South Carolina Charleston South Carolina 29425-0721
Simmons Cancer Center - Dallas Dallas Texas 75235-9154
Cook Children's Medical Center - Fort Worth Fort Worth Texas 76104
Midwest Children's Cancer Center Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 24, 2014 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →